brexucabtagene autoleucel
gilead
['so proud', 'brexu-cel']
so proud to see our senior fellow present his oral abstract at #asco23 on real world outcomes of b-all patients treated with brexu-cel in a multi center national collaborative, with more exciting work to come! 
The 21 fellows of the University of Chicago Hematology/Oncology Fellowship. RT ≠ endorsement